The results showed that GPRC5A positively regulated YAP1, CYR61, cyclin D1, c-Myc and CTGF expression at the transcriptional level, as evidenced by overexpression and knockdown of GPRC5A in pancreatic cancer cells (Fig. 5H, L). This evidence concerns the gene CCN1 and familial pancreatic carcinoma.